The dose escalation pattern is similar but Wegovy has more steps
Some early GLP-1 studies (rightly) sparked concerns about pancreatitis and thyroid tumors based on animal research
Some labels list additives like B12, niacinamide, or L-carnitine
Interestingly, GLP-1 is also known to decrease the rewarding effects of food intake by interacting with parts of the mesolimbic dopamine system such as the ventral tegmental area (VTA), nucleus accumbens (NAc) [34], and also GABAergic circuits in the laterodorsal tegmental nucleus (LDTg) [35], which makes brain GLP-1R signaling a promising target for the treatment of alcohol and cocaine abuse disorders [36, 37]
Traditional approaches to weight loss, such as diet and exercise alone, have proven to be ineffective for many individuals, which is why the introduction of Semaglutide has sparked renewed optimism for those on their weight loss journey
This high-stakes environment puts enormous pressure on stakeholders to innovate quickly while also preparing for what comes next: reinvention as biosimilars and new competitors disrupt the landscape